Bio Protocol vs Bitcoin — how do they compare? Bio Protocol trades at Rp500.53 (market cap Rp1,13T, Rp274,25M 24h volume), while Bitcoin trades at Rp1,124,081,835 (market cap Rp22.479,49T, Rp530,73T 24h volume). The key difference: Bitcoin is far larger — about 19893.4× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 20,1M / 21M BTC (96%) for Bitcoin. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Bitcoin for 105 Days on average.
| BIO | BTC | |
|---|---|---|
Market Cap | Rp1,13T | Rp22.479,49T |
Volume (24h) | Rp274,25M | Rp530,73T |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 20,1M / 21M BTC (96%) |
Typical Hold Time | 16 Days | 105 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Bitcoin is trading at Rp1,120,740,717 with a market cap of Rp22,471.46T, showing neutral technical signals overall. The asset is near full circulation at 96% of its 21 million supply cap. Recent news highlights long-term bullish projections but acknowledges short-term volatility from macroeconomic factors.
Outlook remains cautiously optimistic with strong fundamentals, but investors should be wary of high volatility and regulatory uncertainties. Key opportunities lie in network growth, while risks include price swings and external economic pressures.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →A crypto asset founded in January 2009 by Satoshi Nakamoto. It is the first and most widely used decentralized online currency with the highest market capitalization. Its purpose is to provide a peer-to-peer payment system without the need of third party. The total supply of BTC is limited and pre-defined at 21 million. As of October 2020, there are more than 85% of BTC in circulation.
Read more on BTC →